INTERNATIONAL PATENT: SUNGKWANG MEDICAL FOUNDATION, 의료법인 성광의료재단, CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, 차의과학대학교 산학협력단 FILES APPLICATION FOR "BIOMARKER FOR PREDICTING TREATMENT RESPONSE TO IMMUNOTHERAPY AND GENE PREDICTION MODEL USING SAME"

GENEVA, June 24 -- SUNGKWANG MEDICAL FOUNDATION (566 Nonhyeon-ro,Gangnam-gu,Seoul 06135), 의료법인 성광의료재단 (서울특별시강남구논현로 566), CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (120 Haeryong-roPocheon-siGyeonggi-do 11160), 차의과학대학교 산학협력단 (경기도포천시해룡로 120) filed a patent application (PCT/KR2024/096842) for "BIOMARKER FOR PREDICTING TREATMENT RESPONSE TO IMMUNOTHERAPY AND GENE PREDICTION MODEL USING SAME" on Dec 12, 2024. With publication no. WO/2025/127839...